Variation in the Risk of Suicide Attempts and Completed Suicides by Antidepressant Agent in Adults
|
|
- Juniper Allison
- 5 years ago
- Views:
Transcription
1 WEB-ONLY CONTENT Variation in the Risk of Suicide Attempts and Completed Suicides by Antidepressant Agent in Adults A Propensity Score Adjusted Analysis of 9 Years Data Sebastian Schneeweiss, MD, ScD; Amanda R. Patrick, MS; Daniel H. Solomon, MD, MPH; Jyotsna Mehta, MS; Colin Dormuth, MA, MS, ScD; Matthew Miller, MD, ScD; Jennifer C. Lee, BS; Philip S. Wang, MD, DrPH Arch Gen Psychiatry. 2010;67(5): etable 1. Inclusion Criteria Definitions for Depression a Code Depressive Illness Organic affective syndrome, depressive type 296.2x Major depressive episode, single episode 296.3x Major depressive disorder, recurrent episode Unspecified affective psychosis (eg, melancholia not otherwise specified) 298.0x Depressive-type psychoses 300.4x Neurotic depression 309.0x Brief depressive reaction 309.1x Prolonged depressive reaction Adjustment reaction with anxiety and depression 311 Depressive disorder not elsewhere classified a The codes are from the International Classification of Diseases, Ninth Revision. 24 E1
2 etable 2. Baseline Covariates and Definitions a Demographic Definition Nonpsychiatric Condition Myocardial infarction Inpatient stay with 410.xx as any diagnosis Atherosclerotic disease 440 atherosclerosis; 445 atheroembolism; cerebral atherosclerosis Breast cancer Hospital diagnosis of 174.xx, Chronic lung disease 491.xx chronic bronchitis; 492.x emphysema; 493.xx asthma; 494.x bronchiectasis; 495.xx extrinsic allergic alveolitis; 496 chronic airway obstruction not mentioned elsewhere Diabetes Diagnosis of 250.xx diabetes; polyneuropathy in diabetes; diabetic retinopathy; or diabetic macular edema; plus 1 prescription for any of the following: insulin, acarbose, miglitol, metformin hydrochloride, acetohexamide, chlorpropamide, glimepiride, glipizide, glyburide, repaglinide, tolazamide, tolbutamide, pioglitazone hydrochloride, rosiglitazone maleate, troglitazone, and nateglinide Dyslipidemia 272.xx Gastrointestinal hemorrhage 578.x gastrointestinal hemorrhage; 531.0, 531.2, 531.4, gastric ulcer with hemorrhage; 532.0, 532.2, 532.4, duodenal ulcer with hemorrhage; 533.0, 533.2, 533.4, peptic ulcer with hemorrhage; 534.0, 534.2, 534.4, gastrojejunal ulcer with hemorrhage Glaucoma 365.xx Gout 274.xx Heart failure 428.xx, , , , , , , , , , Ventricular arrhythmia 427.4x, , , 427.5x, 427.1x, Other arrhythmia 427.xx or 426.xx except for 427.4x, , , 427.5x, 427.1x, Congenital heart diseases 745.xx, 746.xx Other congenital anomalies 747.xx of circulatory system Cardiomyopathy 425.xx Rheumatic heart diseases 393.xx-398.xx except for Hypertensive heart and kidney diseases 402.xx-404.xx except for , , , , , , , , Nonrheumatic valve 424.xx Endocarditis, pericarditis, and myocarditis 420.xx, 421.xx, 422.xx Rheumatic fever 390.xx, 391.xx, 392.xx Essential hypertension 401.xx or use of thiazide Secondary hypertension 405.xx Hypothyroidism 243, 244.x Injury other than poisoning 800.xx-959.xx Lung cancer Hospital diagnosis of 162.xx, Osteoarthritis 715.xx Other malignant neoplasm Hospital diagnosis of 140.xx-208.xx excluding lung cancer, breast cancer, prostate cancer, and colorectal cancer codes Other coronary heart disease 411.xx-414.xx Pain requiring high-potency opiates Use of diacetylmorphine hydrochloride, fentanyl citrate, hydromorphone hydrochloride, hydroxyephedrine/ normethadone, meperidine hydrochloride, methadone hydrochloride, morphine sulfate Pain requiring midpotency opiates Use of codeine, hydrocodone bitartrate, oxycodone hydrochloride, pseudoephedrine hydrochloride, drocodone, propoxyphene hydrochloride Parkinson disease 332.0, 332.1, Peptic ulcer disease and related conditions (without hemorrhage) 531.1, 531.3, 531.5, 531.7, gastric ulcer without hemorrhage; 532.1, 532.3, 532.5, 532.7, duodenal ulcer without hemorrhage; 533.1, 533.3, 533.5, 533.7, peptic ulcer without hemorrhage; 534.1, 534.3, 534.5, 534.7, gastrojejunal ulcer without hemorrhage Pneumonia 480.x, 481, 482.xx, 483.x, 484.x, 485, 486 Poisoning or drug toxic effects 960.xx-979.xx poisoning by medicinal and biological substances; 980.xx-989.xx toxic effects of substances chiefly nonmedical as to source Prostate cancer Hospital diagnosis of 185.xx, Colorectal cancer Hospital diagnosis of 153.xx, 230.3x, 154.xx (except 154.2, 154.3, and 154.4), Rheumatoid arthritis 714.x plus disease-modifying antirheumatic drug or steroid use Seizure disorder 345 epilepsy; 345.xx epilepsy; 780.3x convulsion Sepsis 0.38.xx septicemia; systemic inflammatory response syndrome due to infectious process without organ dysfunction Stroke or transient ischemic attack Inpatient diagnosis of 433.x1 occlusion and stenosis of precerebral arteries with infarction; 434.x1 occlusionof cerebral arteries with infarction; 435.x transient cerebral ischemia; 436 acute but ill-defined cerebrovascular disease; 437.1x other generalized ischemic cerebrovascular disease; 437.9x unspecified cerebrovascular disease; 438.x late effects of cerebrovascular disease Urinary incontinence 788.3x (continued) E2
3 etable 2. Baseline Covariates and Definitions (continued) a Demographic Depression c Anxiety or sleep disorder Anxiety disorder Sleep disorder Mania Manic-depressive illness Attention-deficit/hyperactivity disorder Substance abuse Alcohol abuse or dependence Drug abuse or dependence Psychiatric Disorders b Definition 300.0x anxiety states; 300.2x phobic disorders; 300.3x obsessive-compulsive disorders 307.4x specific disorders of sleep of nonorganic origin; 347 cataplexy and narcolepsy; 347.xx cataplexy and narcolepsy; 780.5x sleep disturbances 296.0x manic disorder, single episode; 296.1x manic disorder, recurrent episode; 296.4x bipolar affective disorder, manic; 296.5x bipolar affective disorder, depressed; 296.6x bipolar affective disorder, mixed; 296.7x bipolar affective disorder, unspecified; 296.8x bipolar affective disorder, other and unspecified; other specified affective psychoses (eg, mood swings) 312.xx; 314.xx 291 alcoholic psychoses; 291.0x alcohol withdrawal delirium; 291.1x alcohol amnestic syndrome; 291.2x other alcoholic dementia; 291.3x alcohol withdrawal hallucinosis; 291.4x idiosyncratic alcohol intoxication; 291.5x alcoholic jealousy; 291.8x other specified alcoholic psychosis; 291.9x unspecified alcoholic psychosis; 303 alcohol dependence syndrome; 303.xx alcohol dependence syndrome; 305.0x alcohol abuse 292 drug psychoses; 292.0x drug withdrawal syndrome; 292.1x paranoid and/or hallucinatory state induced by drugs; 292.2x pathological drug intoxication; 292.8x other specified drug-induced mental disorders; 292.9x unspecified drug-induced mental disorder; 304 drug dependence; 304.xx drug dependence; 305.2x-305.9x nondependent abuse of drugs Psychotic disorder 290.8x other specified senile psychotic conditions; 290.9x unspecified senile psychotic condition; 295 schizophrenic disorders; 295.xx schizophrenia; 297 paranoid states; 297.xx paranoid states; 298 other nonorganic psychoses; 298.1x-298.9x other nonorganic psychoses; 299 psychoses with origin specific to childhood; 299.xx psychoses with origin specific to childhood; 780.1x hallucinations Dementia ICD-9 code of 290.0x senile dementia; 290.1x presenile dementia; 290.2x senile dementia with delusional or depressive features; 290.3x senile dementia with delirium; 290.4x arteriosclerotic dementia; 291.1x alcoholic amnestic syndrome; 291.2x other alcoholic dementia; drug-induced dementia; 294 other organic psychotic conditions (chronic); 294.0x amnestic syndrome (nonalcoholic Korsakoff psychosis or syndrome); 294.1x dementia in conditions classified elsewhere; 294.8x other specified organic brain syndromes (chronic); 294.9x unspecified organic brain syndrome (chronic); 330 cerebral degenerations usually manifested in childhood; 330.xx cerebral degenerations usually manifested in childhood; 331.0x Alzheimer disease; 331.1x Pick disease; 331.2x senile degeneration of brain; 331.7x cerebral degeneration in diseases classified elsewhere; 331.8x other cerebral degeneration; 331.9x cerebral degeneration, unspecified Other psychiatric disorder Delirium Personality disorders Other mental disorders Electroconvulsive therapy Concurrent lithium use Concurrent use of anticonvulsants or bipolar disorder medications presenile dementia with delirium; 290.3x senile dementia with delirium; arteriosclerotic dementia with delirium; 291.0x alcoholic delirium; drug-induced delirium; 293 transient organic psychotic conditions; 293.0x acute delirium; 293.1x subacute delirium; 293.8x other specified transient organic mental disorder; 293.9x unspecified transient organic mental disorder; 348.3x encephalopathy, unspecified; toxic encephalopathy 301 personality disorders; 301.xx personality disorders 300.1x hysteria; 300.5x-300.9x other neurotic disorder; 302 sexual deviations and disorders; 302.xx sexual deviations and disorders; 306 physiological malfunction arising from mental factors; 306.xx physiological malfunction arising from mental factors; 307.0x-307.3x special symptoms or syndromes not elsewhere classified; 307.5x-307.9x special symptoms or syndromes not elsewhere classified; 308 acute reaction to stress; 308.xx acute reaction to stress; 309.2x-309.9x adjustment reaction with disturbance other than depressed mood; 310 specific nonpsychotic mental disorders due to organic brain damage; 310.xx specific nonpsychotic mental disorders due to organic brain damage; 313 disturbance of emotions specific to childhood or adolescence; 313.xx disturbance of emotions specific to childhood or adolescence; 315 specific delays in development; 315.xx specific delays in development; 316 psychic factors associated with diseases classified elsewhere; 316.xx psychic factors associated with diseases classified elsewhere Psychiatric Treatment Physician billing code for electroconvulsive therapy in 6 months prior to treatment initiation Prescription for lithium during the 6 months prior to antidepressant initiation with adequate days supply to cover the antidepressant initiation date Prescription for valproate sodium/divalproex sodium, carbamazepine, lamotrigine, olanzapine, quetiapine fumarate, aripiprazole, ziprasidone hydrochloride, or risperidone during the 6 months prior to antidepressant initiation with adequate days supply to cover the antidepressant initiation date Abbreviation: ICD-9, International Classification of Diseases, Ninth Revision. 24 a The codes are from the ICD b Defined as having 1 or more hospitalizations with the condition recorded or 2 or more physician claims with the condition recorded. c Because all patients have qualified via one of these codes, this variable does not act as a confounder but is listed here only for completeness. E3
4 etable 3. Event Hazard Ratios for Composite and Violent Composite Outcomes During 6-Month Follow-up Comparing Other Selective Serotonin Reuptake Inhibitors vs Fluoxetine and Comparing Other Antidepressant Classes vs Selective Serotonin Reuptake Inhibitors a HR (95% CI) Composite Outcome Violent Suicide Completed Suicide Adjusted for Age, Sex, and Calendar Year Adjusted for Propensity Score Decile c Adjusted for Propensity Score Decile c Adjusted for Propensity Score Decile c Antidepressant b Unadjusted All Adults Citalopram 0.62 ( ) 0.92 ( ) 0.69 ( ) 0.25 ( ) 0.78 ( ) Fluvoxamine 1.26 ( ) 1.33 ( ) 1.09 ( ) 0.99 ( ) 0.78 ( ) Paroxetine 0.95 ( ) 1.12 ( ) 0.94 ( ) 0.62 ( ) 0.48 ( ) Sertraline 0.72 ( ) 0.83 ( ) 0.69 ( ) 0.48 ( ) 0.63 ( ) Class SNRIs 1.09 ( ) 1.18 ( ) 1.20 ( ) 0.81 ( ) 0.68 ( ) MAOIs 0.71 ( ) 0.62 ( ) 0.63 ( ) No events No events Other newer and atypical agents 0.90 ( ) 0.93 ( ) 0.91 ( ) 0.93 ( ) 1.03 ( ) TCAs 0.96 ( ) 1.04 ( ) 1.05 ( ) 0.48 ( ) 0.34 ( ) Treatment-Naive Adults d Citalopram 0.78 ( ) 0.95 ( ) 0.97 ( ) 0.26 ( ) 0.53 ( ) Fluvoxamine 1.12 ( ) 1.25 ( ) 1.01 ( ) 0.63 ( ) 0.66 ( ) Paroxetine 1.02 ( ) 1.11 ( ) 1.01 ( ) 0.52 ( ) 0.63 ( ) Sertraline 0.83 ( ) 0.95 ( ) 0.77 ( ) 0.32 ( ) 0.62 ( ) Class SNRIs 1.13 ( ) 1.14 ( ) 1.17 ( ) 0.61 ( ) 0.53 ( ) MAOIs 1.02 ( ) 1.12 ( ) 1.05 ( ) No events No events Other newer and atypical agents 0.91 ( ) 0.97 ( ) 0.98 ( ) 0.93 ( ) 1.04 ( ) TCAs 1.10 ( ) 1.26 ( ) 1.31 ( ) 0.47 ( ) 0.33 ( ) Adults With No Prior Suicide Attempt Citalopram 0.63 ( ) 0.91 ( ) 0.76 ( ) 0.25 ( ) 0.41 ( ) Fluvoxamine 1.29 ( ) 1.36 ( ) 1.14 ( ) 0.99 ( ) 0.78 ( ) Paroxetine 0.93 ( ) 1.08 ( ) 0.92 ( ) 0.52 ( ) 0.39 ( ) Sertraline 0.75 ( ) 0.87 ( ) 0.72 ( ) 0.48 ( ) 0.63 ( ) Class SNRIs 1.10 ( ) 1.18 ( ) 1.21 ( ) 0.82 ( ) 0.75 ( ) MAOIs 0.74 ( ) 0.65 ( ) 0.67 ( ) No events No events Other newer and atypical agents 0.91 ( ) 0.95 ( ) 0.92 ( ) 0.98 ( ) 1.11 ( ) TCAs 1.00 ( ) 1.08 ( ) 1.09 ( ) 0.50 ( ) 0.36 ( ) Abbreviations: CI, confidence interval; HR, hazard ratio; MAOIs, monoamine oxidase inhibitors; SNRIs, serotonin-norepinephrine reuptake inhibitors;, selective serotonin reuptake inhibitors; TCAs, tricyclic agents. a Outcomes indicate attempted and completed suicide. The reference group for the SSRI comparisons is fluoxetine hydrochloride (Prozac); the reference group for the antidepressant drug class comparisons is. The MAOIs were not investigated owing to the small numbers of exposed subjects. b Citalopram indicates citalopram hydrobromide (Celexa); fluvoxamine, fluvoxamine maleate (Luvox); paroxetine, paroxetine hydrochloride (Paxil); sertraline, sertraline hydrochloride (Zoloft); and SNRIs, venlafaxine hydrochloride. c The propensity score includes demographic, psychiatric, and general clinical covariates listed in etable 2. d No antidepressant use in the past 3 years. E4
5 Composite Event-Free Probability DComposite Event-Free Probability CComposite Event-Free Probability BComposite Event-Free Probability A Citalopram hydrobromide Fluvoxamine maleate Paroxetine hydrochloride Sertraline hydrochloride efigure 1. Attempted suicide free and completed suicide free survival in pairwise comparisons of selective serotonin reuptake inhibitors citalopram hydrobromide (A), fluvoxamine maleate (B), paroxetine hydrochloride (C), and sertraline hydrochloride (D) with fluoxetine hydrochloride, multivariate adjusted by the inverse probability of treatment. E5
6 AComposite Event-Free Probability BComposite Event-Free Probability CComposite Event-Free Probability MAOIs Other newer and atypical agents TCAs efigure 2. Attempted suicide free and completed suicide free survival in pairwise comparisons of monoamine oxidase inhibitors (MAOIs) (A), other newer and atypical agents (B), and tricyclic agents (TCAs) (C) with selective serotonin reuptake inhibitors (), multivariate adjusted by the inverse probability of treatment. E6
Supplementary Online Content
Supplementary Online Content Gomes T, Redelmeier DA, Juurlink DN, et al. Opiod dose and risk of road trauma in Canada: a populationbased study. JAMA Intern Med. Published online January 14, 2013. doi:10.1001/2013.jamainternmed.733.
More informationIndex. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
More informationSupplementary Online Content
Supplementary Online Content Lee C-C, Lee M-tG, Chen Y-S. Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone. JAMA Internal Medicine. Published online October 5, 2015.
More informationProvider Bulletin Philadelphia Department of Behavioral Health Community Behavioral Health State Allowable ICD-9-CM Codes.
Provider Bulletin 07-01 Philadelphia Department of Behavioral Health Community Behavioral Health State Allowable ICD-9-CM Codes. February 12, 2007 The Commonwealth of Pennsylvania lists the allowable ICD-9-CM
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationManual of Clinical Psychopharmacology
Manual of Clinical Psychopharmacology Fourth Edition Alan F. Schatzberg, M.D. Kenneth T. Norris, Jr., Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School
More informationSupplementary Online Content
Supplementary Online Content Dharmarajan K, Wang Y, Lin Z, et al. Association of changing hospital readmission rates with mortality rates after hospital discharge. JAMA. doi:10.1001/jama.2017.8444 etable
More informationDepression. University of Illinois at Chicago College of Nursing
Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors
More informationDrugs, Society and Behavior
SOCI 270 Drugs, Society and Behavior Spring 2016 Professor Kurt Reymers, Ph.D. Chapter 8 Medication for Mental Disorders 1. Mental Disorders: a. The Medical Model Model: symptoms diagnosis determination
More informationEpisodes of Care Risk Adjustment
Episodes of Care Risk Adjustment Episode Types Wave 1 Asthma Acute Exacerbation Perinatal Total Joint Replacement Wave 2 Acute Percutaneous Coronary Intervention COPD Acute Exacerbation Non-acute Percutaneous
More informationAntidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database
open access Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database Carol Coupland, 1 Trevor Hill, 1 Richard Morriss,
More informationTreat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
More informationPrepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D.
Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D. Sources: National Institute of Mental Health (NIMH), the National Alliance on Mental Illness (NAMI), and from the American Psychological Association
More informationUsing 3-Digit ICD-9-CM Codes with the Elixhauser Comorbidity Index
Congestive Heart Failure 398.91 Rheumatic heart failure (congestive) 398 Other rheumatic heart disease 402.01, 402.11, 402.91 402 Hypertensive heart disease 404.01, 404.03, 404.11, 404.13, 404.91, 404.93
More informationClinical Guideline for the Management of Bipolar Disorder in Adults
Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:
More informationDISEASES AND DISORDERS
DISEASES AND DISORDERS 13. The mood (affective) disorders 99 14. The psychotic disorders: schizophrenia 105 15. The anxiety and somatoform disorders 111 16. Dementia and delirium 117 17. Alcohol and substance-related
More informationSpecialty Mapping Guides ICD-9 to ICD-10
Specialty Mapping Guides ICD-9 to ICD-10 The conversions contained within this crosswalk were the most current version at the time of development. All efforts should be made by the attendee to stay current
More informationSupplementary Online Content
Supplementary Online Content Lau WCY, Chan EW, Cheung CL, et al. Association between dabigatran vs warfarin and risk of osteoporotic fractures among patients with nonvalvular atrial fibrillation. JAMA.
More informationPSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
More informationAnti- Depressants, Mood Stabilizers: What Works Best For Bipolar Disorder? Date: March 30, 2007 Source: NIH/National Institute of.
30-3-2007 Anti- Depressants, Mood Stabilizers: What Works Best For Bipolar Disorder? Date: March 30, 2007 Source: NIH/National Institute of. 30-3-2018 C. Psychiatric drugs: controlled trial demonstrated
More informationAntidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database
open access Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database Carol Coupland, 1 Trevor Hill, 1 Richard Morriss, 2 Michael Moore, 3
More informationAntidepressant use and risk of adverse outcomes in people aged years: cohort study using a primary care database
Coupland et al. BMC Medicine (2018) 16:36 https://doi.org/10.1186/s12916-018-1022-x RESEARCH ARTICLE Open Access Antidepressant use and risk of adverse outcomes in people aged 20 64 years: cohort study
More informationIdentifying and evaluating patterns of prescription opioid use and associated risks in Ontario, Canada Gomes, T.
UvA-DARE (Digital Academic Repository) Identifying and evaluating patterns of prescription opioid use and associated risks in Ontario, Canada Gomes, T. Link to publication Citation for published version
More informationAnti-Depressant Medications
Anti-Depressant Medications A Introduction: This topic may be a little bit underestimated here in Jordan, while in western countries it has more significance. The function of anti-depressants is to change
More informationGuilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant.
1-800-PSYCH If you are obsessive-compulsive, dial 1 repeatedly If you are paranoid-delusional, dial 2 and wait, your call is being traced If you are schizophrenic, a little voice will tell you what number
More informationICD-9-CM CODING FUNDAMENTALS CODING EXERCISES
Steps to Accurate Coding Underline the main term, then locate code: Stenosis of Carotid Artery Transient Ischemic Attack Gastrointestinal hemorrhage Degenerative Joint Disease Coronary Artery Disease Alcoholic
More informationSupplementary Online Content
Supplementary Online Content Blumenthal SR, Castro VM, Clements CC, et al. An electronic health records study of long-term weight gain following antidepressent use. JAMA Psychiatry. Published online June
More informationTreatment Options for Bipolar Disorder Contents
Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8
More informationCrosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15
1 1500 MALIGNANT NEOPLASM OF CERVICAL ESOPHAGUS 1 1501 MALIGNANT NEOPLASM OF THORACIC ESOPHAGUS 1 1502 MALIGNANT NEOPLASM OF ABDOMINAL ESOPHAGUS 1 1503 MALIGNANT NEOPLASM OF UPPER THIRD OF ESOPHAGUS 1
More informationSupplementary Online Content
Supplementary Online Content Huybrechts KF, Hernández-Díaz S, Patorno E, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry. Published online August 17, 2016.
More informationTable of substance use disorder diagnoses:
Table of substance use disorder diagnoses: ICD-9 Codes Description 291 Alcohol withdrawal delirium 291.3 Alcohol-induced psychotic disorder with hallucinations 291.4 Idiosyncratic alcohol intoxication
More informationNotifiable Medical Conditions
Notifiable Medical Conditions A Acoustic neuroma Addison s disease Agoraphobia AIDS Alcohol problems Alzheimer s disease Amyotrophic Lateral Sclerosis - see Motor Neurone Disease Amputations Aneurysm Angina
More informationCardiovascular Health and Diabetes Screening for People with Schizophrenia
Cardiovascular Health and Diabetes Screening for People with Schizophrenia The percentage of members 25 years and older with a schizophrenia diagnosis and who were prescribed any antipsychotic medication,
More informationPsychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis
Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious
More informationDrugs for Emotional and Mood Disorders Chapter 16
Drugs for Emotional and Mood Disorders Chapter 16 NCLEX-RN Review Question 1 Choices Please note Question #1 at the end of Ch 16 pg 202 & Key pg 805 answer is #4 1. Psychomotor symptoms 2. Tachycardia,
More informationDepression in Pregnancy
TREATING THE MOTHER PROTECTING THE UNBORN A MOTHERISK Educational Program The content of this program reflects the expression of a consensus on emerging clinical and scientific advances as of the date
More informationPRESCRIBING GUIDELINES
The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors
More informationAsthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus
A Fib & Flutter I48.0 Paroxysmal atrial fibrillation I48.1 Persistent atrial fibrillation I48.2 Chronic atrial fibrillation I48.3 Typical atrial flutter Asthma J45.20 Mild, uncomplicated J45.21 Mild, with
More informationTENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 8 Episodes
TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 8 Episodes Acute Seizure, Syncope, Acute Gastroenteritis, Pediatric Pneumonia, Bronchiolitis, Colposcopy, Hysterectomy,
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationPsychobiology Handout
Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are
More informationSupplementary Online Content
Supplementary Online Content Renoux C, Vahey S, Dell Aniello S, Boivin J-F. Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurol. Published
More information0301 Anemia Others. Endocrine nutritional and metabolic disorders Others Vascular dementia and unspecified dementia
Certain infectious and parasitic diseases 0101 Intestinal infectious diseases 0102 Tuberculosis 0103 Infections with a predominantly sexual mode of transmission 0104 Viral infections characterized by skin
More informationAffective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018
Affective or Mood Disorders Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Reactive Depression. Secondary: Medical Neurological Drugs Major (Endogenous) Depression = Unipolar: Depressed
More informationPRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA
CASE #1 PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA OBJECTIVES Epidemiology Presentation in older adults Assessment Treatment
More informationSupplementary Materials for
Supplementary Materials for Williamson T, Green ME, Birtwhistle R, et al. Validating the 8 CPCSSN case definitions for chronic surveillance in a primary care database of electronic health records. Ann
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX
A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release
More informationDefinitions of chronic conditions used to define the number of serious comorbidities in the study.
Supplementary Table 1 Definitions of chronic conditions used to define the number of serious comorbidities in the study. Comorbidity ICD-9 Code Description CAD/MI 410.x Acute myocardial infarction 411.x
More informationSupplementary Online Content
Supplementary Online Content Guimarães PO, Krishnamoorthy A, Kaltenbach LA, et al. Accuracy of medical claims for identifying cardiovascular and bleeding events after myocardial infarction: a secondary
More informationFY 2017 ICD-10-CM Code Updates
FY 2017 ICD-10-CM Code Updates Webinar I Presented by: Melanie Endicott, MBA/HCM, RHIA, CHDA, CDIP, CCS, CCS-P, FAHIMA AHIMA- Approved ICD-10-CM/PCS Trainer Senior Director, HIM Practice Excellence, AHIMA
More informationAppendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)
Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Introduction / Background Treatment comes after diagnosis Diagnosis is based on
More informationDepression major depressive disorder. Some terms: Major Depressive Disorder: Major Depressive Disorder:
Depression major depressive disorder Oldest recognized disorder: melancholia It is a positive and active anguish, a sort of psychical neuralgia wholly unknown to normal life. - William James "I am now
More informationBlood pressure and pulse should be recorded on a centile chart at each dose adjustment and then at least every 6 months
Checklist 1: checklist before prescribing Amfexa 5mg, 10mg and 20mg Tablets It is recommended that this checklist be used in conjunction with the SmPCs for Amfexa Tablets (which can be accessed at http://www.medicines.org.uk/emc/search
More informationPsychotropic Drugs 0, 4-
0, 4- } -v Psychotropic Drugs NORMAN L. KELTNER, Ed D, RN Associate Professor, Graduate Program, University of Alabama School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama DAVID
More informationAntipsychotics and stroke risk
Integrating Sentinel into Routine Regulatory Drug Review: A Snapshot of the First Year Antipsychotics and stroke risk Lockwood G. Taylor, PhD, MPH Division of Epidemiology II Office of Pharmacovigilance
More informationDiagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD
Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty
More informationKentucky Department for Medicaid Services. Pharmacy and Therapeutics Advisory Committee Recommendations. November 18, 2010 Meeting
Kentucky Department for Medicaid Services Pharmacy and Therapeutics Advisory Committee Recommendations November 18, 2010 Meeting The following chart provides a summary of the recommendations that were
More informationPrimary Care Management of Depression. John Briles, MD, Medical Director October 11, 2017
John Briles, MD, Medical Director October 11, 2017 Molina Healthcare of Michigan uses a HEDIS measure for Antidepressant Medication Management (AMM) to measure how well treating providers (PCPs) appropriately
More informationJohn E. Kraus, M.D., Ph.D.
John E. Kraus, M.D., Ph.D. Chief, Adult Psychiatry, Dorothea Dix Hospital, Raleigh, NC Assistant Professor/Associate Director of Residency Training, Dept. of Psychiatry, UNC Hospitals, Chapel Hill, NC
More informationMental Health Nursing: Mood Disorders. By Mary B. Knutson, RN, MS, FCP
Mental Health Nursing: Mood Disorders By Mary B. Knutson, RN, MS, FCP A Definition of Mood Prolonged emotional state that influences the person s whole personality and life functioning Adaptive Functions
More informationMedication Guide Fluoxetine Oral Solution USP What is the most important information I should know about fluoxetine oral solution?
Medication Guide Fluoxetine Oral Solution USP Read the Medication Guide that comes with fluoxetine before you start taking it and each time you get a refill. There may be new information. This Medication
More informationStudent Outline. Improving Transportation Safety: Commercial Driver Medical Examiner Training CHAPTER 1. General FMCSA Information
Student Outline CHAPTER 1 General FMCSA Information FMCSA Mission Statement / Dedicated to Safety / NRCME Important Definitions Regulations Vs. Medical Guidelines Privacy and the Medical Examination 13
More informationVNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017
Effective: 01/01/2017 Updated 11/2016 ANTI-INFLAMMATORY AGENTS - GI DIPENTUM PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS. ANTICONVULSANTS APTIOM BANZEL FYCOMPA GABITRIL OXTELLAR XR POTIGA
More informationCOMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*
COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* Bupropion (Wellbutrin) Start: IR-100 mg bid X 4d then to 100 mg tid; SR-150
More informationSelected tables standardised to Segi population
Selected tables standardised to Segi population LIST OF TABLES Table 4.2S: Selected causes of death, all-ages, 2000 2004 (Segi Standard) Table 5.3S: Public hospitalisations by major cause of admission
More informationICD. International Classification of Diseases
ICD International Classification of Diseases ICD international standard diagnostic classification for general epidemiological health management purposes clinical use analysis of the general health situation
More informationSupplementary Figure 1. Kaplan Meier plots of the association of anti-inflammatory medication (acetyl salicylic acids (ASA), non-steroid
Supplementary Figure 1. Kaplan Meier plots of the association of anti-inflammatory medication (acetyl salicylic acids (ASA), non-steroid anti-inflammatory drugs (NSAID) and statin) with early depression
More informationS2 File. Clinical Classifications Software (CCS). The CCS is a
S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous
More informationMental Health Pathway
Mental Health Pathway Triggers for Mental Health Pathway Information for professionals Consider mainstream Mental Health Services (Green light Toolkit) Clinical Interface Protocol Clinical Assessment Information
More informationSupplementary Online Content
Supplementary Online Content Berkowitz SA, Krumme AA, Avorn J, et al. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study. JAMA
More informationTable S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture
Technical Appendix Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture and Associated Surgical Treatment ICD 9 Code Descriptions Hip Fracture 820.XX Fracture neck of femur 821.XX
More informationPsychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI
Regional Affective Disorders Service Psychopharmacology Northumberland, Tyne and Wear NHS Trust Hamish McAllister-Williams Reader in Clinical Psychopharmacology Department of Psychiatry, RVI Intro NOT
More informationFOLLOW-UP AFTER EMERGENCY DEPARTMENT VISIT FOR PEOPLE WITH HIGH-RISK MULTIPLE CHRONIC CONDITIONS (FMC) HEDIS (Administrative)
FOLLOW-UP AFTER EMERGENCY DEPARTMENT VISIT FOR PEOPLE WITH HIGH-RISK MULTIPLE CHRONIC CONDITIONS (FMC) APPLICATIONS OBJECTIVE Purpose of Measure: ELIGIBLE POPULATION Which members are included? STANDARD
More informationPsychiatry in Primary Care: What is the Role of Pharmacist?
Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure
More informationDepression in Late Life
Depression in Late Life Robert Madan MD FRCPC Geriatric Psychiatrist Key Learnings Robert Madan MD FRCPC Key Learnings By the end of the session, participants will be able to List the symptoms of depression
More informationMood Disorders.
Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More informationTreatment-resistant depression in primary care
Treatment-resistant depression in primary care Interprofessional CME, October 2017 Brian J. Mickey, MD, PhD Associate Professor School of Medicine Department of Psychiatry Disclosures Speakers bureau:
More informationMajor Depressive Disorder (MDD) in Children under Age 6
in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 6. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian
More information(levomilnacipran) extended-release capsules
MEDICATION GUIDE FETZIMA (fet-zee-muh) (levomilnacipran) extended-release capsules Read this Medication Guide before you start taking FETZIMA and each time you get a refill. There may be new information.
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More informationWeb extras. Appendix Read codes used for depression and severity.
Web extras Appendix Read codes used for depression and severity. Read codes used for identification of patients diagnosed with depression, and their severity classification. The severity classification
More informationCost-of-Illness Summaries for Selected Conditions
January 2006 RTI International RTI-UNC Center of Excellence in Health Promotion Economics Costs (in billions of $) Costs adjusted to 2004 (in billions of $) Disease Total Direct Indirect Intangible Total
More informationDiagnosis-specific morbidity - European shortlist
I Certain infectious and parasitic diseases 1 Tuberculosis A15-A19 X X Z 2 Sexually transmitted diseases (STD) A50-A64 Y Z 3 Viral hepatitis (incl. hepatitis B) B15-B19 X Z 4 Human immunodeficiency virus
More informationMedication Guide SARAFEM (SAIR-a-fem) (fluoxetine hydrochloride) Tablets
Medication Guide SARAFEM (SAIR-a-fem) (fluoxetine hydrochloride) Tablets Read the Medication Guide that comes with SARAFEM before you start taking it and each time you get a refill. There may be new information.
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationPsychiatric Medication Guide
Psychiatric Medication Guide F O R : N E O N P R I M A R Y H E A L T H C A R E P R O V I D E R S B Y : M I C H E L L E R O M E R O, D O M A Y, 2 0 1 3 Anti-depressants TCA s & MAOI s (Tricyclic Antidepressants
More informationMedication Guide. What is the most important information I should know about SYMBYAX? SYMBYAX may cause serious side effects, including:
1 Medication Guide SYMBYAX (SIM-be-ax) (olanzapine and fluoxetine) Capsule Read the Medication Guide that comes with SYMBYAX before you start taking it and each time you get a refill. There may be new
More informationGuide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
More informationArchived SECTION 18 - DIAGNOSIS CODES. Section 18 - Diagnosis Codes 18.1 GENERAL INFORMATION PRIOR CONTENTS NO LONGER APPLICABLE...
SECTION 18 - DIAGNOSIS CODES 18.1 GENERAL INFORMATION... 2 18.2 PRIOR CONTENTS NO LONGER APPLICABLE... 2 18.3 DIAGNOSIS CODE LISTING... 2 Ambulance Manual 1 SECTION 18 DIAGNOSIS CODES 18.1 GENERAL INFORMATION
More informationClass: Treatment with Medication:
Class: As we have not finished all the material covering disorders, I wanted to give you and overview of some disorders we have not had a chance to discuss. I feel you are well prepared in different types
More informationSupplementary Methods
Supplementary Materials for Suicidal Behavior During Lithium and Valproate Medication: A Withinindividual Eight Year Prospective Study of 50,000 Patients With Bipolar Disorder Supplementary Methods We
More informationFROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY
13 th Pearl Leibovitch Clinical Day November 18th, 2014 Mounir H. Samy, MD, FRCP(C) Associate Professor of Psychiatry McGill University (ret.) FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD
More informationGLUCOSE TESTING-BLOOD
648.83 ABNORMAL GLUCOSE TOLERANCE COMPLICATING PREGNANCY, CHILDBIRTH OR THE PUERPERIUM, ANTEPARTUM CONDITION OR 648.84 ABNORMAL GLUCOSE TOLERANCE COMPLICATING PREGNANCY, CHILDBIRTH OR THE PUERPERIUM, POSTPARTUM
More informationBipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression
Bipolar Disorder J. H. Atkinson, M.D. Professor of Psychiatry HIV Neurobehavioral Research Programs University of California, San Diego KETHEA, Athens Slides courtesy of John Kelsoe, M.D. Bipolar Disorder
More informationAre All Older Adults Depressed? Common Mental Health Disorders in Older Adults
Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Cherie Simpson, PhD, APRN, CNS-BC Myth vs Fact All old people get depressed. Depression in late life is more enduring and
More informationBIOLOGICAL TREATMENT IN PSYCHIATRY. PTE ÁOK Dept.of Psychiatry Pécs
BIOLOGICAL TREATMENT IN PSYCHIATRY PTE ÁOK Dept.of Psychiatry Pécs 1 SGA effects pharmacokinetic effect chemical strucrure Receptor block D2 5-HT2 α1 H-1 M Selectíve DA (D2D3) antagonists Benzamids Amisulpiride
More information25 Things To Know. mood. disorders
25 Things To Know mood disorders Mood Disorders Depression Bipolar Anxiety Depression Major Depressive Disorder Lasts for weeks at a time Depression Symptoms Lack energy & pleasure Helpless Sad Depression
More informationDepression, anxiety, and obesity
Depression, anxiety, and obesity 5As Team Learning modules Depression and anxiety are two prevalent mood disorders that affect Canadians, with as many as 40-70% of overweight/obese individuals at high
More informationMental illness A Broad Overview. Dr H Pathmanandam March 2017
Mental illness A Broad Overview Dr H Pathmanandam March 2017 Introduction Mental disorders are common in primary and secondary care Many are not recognised and not treated Some receive unnecessary or inappropriate
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More information